Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the resitra (spanish network of infection in transplantation) cohort

Clinical Infectious Diseases

Volumn 48, Issue 12, 2009, Pages 1657-1665

  Torre Cisneros, Julián ^a,b   Doblas, Antonio ^b   Aguado, José María ^c   Juan, Rafael San ^c   Blanes, Marino ^g   Montejo, Miguel ^h   Cervera, Carlos ⁱ   Len, Oscar ^j   Carratala, Jordi ^k   Cisneros, José Miguel ^l   Bou, Germán ^m   Muñoz, Patricia ^d   Ramos, Antonio ^e   Gurgui, Merce ^k   Borrell, Nuria ⁿ   Fortún, Jesus ^f   Moreno, Asunción ⁱ   Gavalda, Joan ^j  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ Hospital Clinic   (Spain)

^j Hospital Universitario de Vall d'Hebron   (Spain)

^k HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^l HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^m HOSPITAL JUAN CANALEJO   (Spain)

ⁿ HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SPAIN; TUBERCULOSIS;

ADULT; AGE FACTORS; FEMALE; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TUBERCULOSIS;

EID: 66949116721     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599035     Document Type: Article

References (31)

1. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid- organ transplant recipients: impact and implications for management. Clin Infect Dis 1998;27:1266-77.
2. Miñoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40:581-7.
3. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group (GESITRA). Transplantation 1997;63:1278-86.
4. Muñoz P, Palomo J, Muñoz R, Rodriguez-Creixems M, Pelaez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995;21: 398-402.
5. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pi- patpanawong K, Mavichak V. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplant Proc 2008; 40:2376-9.
6. Zhang XF, Lv Y, Xue WJ, et al. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China. Transplant Proc 2008;40:1382-5.
7. Chou NK, Wang JL, Chi NH, et al. Tuberculosis after heart transplantation: twenty years of experience in a single center in Taiwan. Transplant Proc 2008;40:2631-3.
8. Basiri A, Moghaddam SM, Simforoosh N, et al. Preliminary report of a nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation. Transplant Proc 2005;37: 3041-4.
9. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17:274-83.
10. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001;60: 1148-53.
11. Jie T, Matas AJ, Gillingham KJ, Sutherland DE, Dunn DL, Humar A. Mycobacterial infections after kidney transplant. Transplant Proc 2005; 37:937-9.
12. Rodríguez E, Díaz O, Hernández M, Hernández G, Tello O. Casos de tuberculosis declarados a la Red Nacional de Vigilancia Epidemiológica. Centro Nacional de Epidemiología. Boletiin Epidemiológico Semanal 2007; 18:205-8.
13. Garrido-Cantarero G, Matesanz-Acedos R. Epidemiology of transplantation in Spain. Enferm Infecc Microbiol Clin 2007; 25:54-62.
14. Spanish Network of Infection in Transplantation (RESITRA). Definiciones RESITRA. In: RESITRA Network. Available at: http://www resitra.retics.net/web/ index.asp. Accessed 11 October 2008.
15. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2008. Available at: http: //www.who.int/tb/publications/global-report/2008/pdf/fullreport.pdf. Accessed 12 October 2008.
16. World Health Organization (WHO). Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuber culosis among adults and adolescents: recommendations for HIV- prevalent and resource-constrained settings. Geneva: WHO, 2007. Available at: http://whqlibdoc.who.int/hq/ 2007/WHO-HTM-TB-2007.379-eng.pdf. Accessed 12 October 2008.
17. de la Camara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in He- matopoietic Transplantation. Bone Marrow Transplant 2000; 26:291-8.
18. Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez- Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003;9:518-25.
19. Bravo C, Roldan J, Roman A, et al. Tuberculosis in lung transplant recipients. Transplantation 2005; 79:59-64.
20. Morales P, Briones A, Torres JJ, Sole A, Perez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005; 37:4050-5.
21. Torre-Cisneros J, Caston JJ, Moreno J, et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004;77:1376-80.
22. Torres J, Aguado JM, San Juan R, et al. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transpl Int 2008; 21:873-8.
23. Basiri A, Hosseini-Moghaddam SM, Simforoosh N, et al. The risk factors and laboratory diagnostics for post renal transplant tuberculosis: a case-control, country-wide study on definitive cases. Transpl Infect Dis 2008; 10:231-5.
24. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 2005; 11:195-202.
25. Codeluppi M, Cocchi S, Guaraldi G, et al. Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant Proc 2006;38:1083-5.
26. Rey R, Ausina V, Casal M, et al. Current status of tuberculosis in Spain: a precarious health care perspective with regard to developed countries [in Spanish]. Med Clin (Barc) 1995; 105:703-7.
27. Caminero Luna JA. The project of a national control program for tuberculosis in Spain [in Spanish]. Med Clin (Barc) 1998; 110:25-31.
28. Ayats-Ardite J, Cisneros-Herreros JM, Perez-Saenz JL, de la Torre- Cisneros J. Infectious disease assessment in solid organ transplant candidates. Enferm Infecc Microbiol Clin 2002; 20:448-61.
29. Ergun I, Ekmekci Y, Sengul S, et al. Mycobacterium tuberculosis infection in renal transplant recipients. Transplant Proc 2006; 38:1344-5.
30. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002; 17(Suppl 4):39-43.
31. Meyers BR, Papanicolaou GA, Sheiner P, Emre S, Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens. Transplantation 2000; 69:64-9.